Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.2 USD | +2.56% | +7.74% | +30.72% |
12:42pm | Raymond James Initiates Third Harmonic Bio With Outperform Rating, $18 Price Target | MT |
05-20 | Third Harmonic Bio Insider Sold Shares Worth $331,066, According to a Recent SEC Filing | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
THIRD HARMONIC BIO, INC. | Bio Therapeutic Drugs | +3.54% | +7.74% | +30.72% | +174.71% | - | 567M |
- Stock Market
- Equities
- THRD Stock
- Charts Third Harmonic Bio, Inc.
- Relative Strength Chart